| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Delegating - Ten Questions to Assess Your Skills |
|
Just Other Articles - Delegating - Ten Questions to Assess Your Skills
Delegating....we all know we should do it, yet many of us find myriad reasons to avoid it. I even heard someo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ne recently state that delegating is just a traditional management tool that doesn’t apply in his fast-paced ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in orld. He told me that he just wants everyone to roll up their sleeves and pitch in where they are needed....w lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. thout prompting. Now that’s an interesting idea. Evidently he wants them to know exactly what to do without here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe xplanation, without a clear grasp of their level of authority or any confusion about roles. In other words, t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is manager wants a team of mind-readers! He probably gets frustrated and annoyed when conflicts arise due to ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ack of communication, and is mystified by the problems he’s created. I’ll grant you that the ability to dele easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ate work is a management skill that has been dissected and taught for decades. It’s not old-fashioned, howeve nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically , and it is still just as important to an organization’s success. Ask yourself a few introspective questions and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ?
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a /li>
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod here are only one or two people on my team with the skills to handle delegated tasks?
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hat a manager needs to be able to perform any task required of the work unit?
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen I tend to micro-manage tasks that have been delegated?
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ear that an employee won’t get it done on time?
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust is already overworked?
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de el of authority? If you answered “yes” to 5 or more of these questions, then it may be time to che elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip k out Delegating Smartly, one of 23 NetSpeed Leadership modules. Your team will thank you for delegating well tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Five Reasons for Fundraising Failures MBA Schools Hone Business Skills
|